These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8419310)

  • 1. 5,10-Dideazatetrahydrofolic acid (DDATHF) transport in CCRF-CEM and MA104 cell lines.
    Pizzorno G; Cashmore AR; Moroson BA; Cross AD; Smith AK; Marling-Cason M; Kamen BA; Beardsley GP
    J Biol Chem; 1993 Jan; 268(2):1017-23. PubMed ID: 8419310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of the disparate antitumor activities of (6R)-5,10-dideaza-5,6,7,8-tetrahydrofolate and methotrexate toward human lymphoblastic leukemia cells, characterized by severely impaired antifolate membrane transport.
    Matherly LH; Angeles SM; McGuire JJ
    Biochem Pharmacol; 1993 Dec; 46(12):2185-95. PubMed ID: 7506026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of carrier-mediated transport of folates and antifolates in methotrexate-sensitive and-resistant leukemia cells.
    Jansen G; Mauritz RM; Assaraf YG; Sprecher H; Drori S; Kathmann I; Westerhof GR; Priest DG; Bunni M; Pinedo HM; Schornagel JH; Peters GJ
    Adv Enzyme Regul; 1997; 37():59-76. PubMed ID: 9381986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple mechanisms of resistance to methotrexate and novel antifolates in human CCRF-CEM leukemia cells and their implications for folate homeostasis.
    Mauritz R; Peters GJ; Priest DG; Assaraf YG; Drori S; Kathmann I; Noordhuis P; Bunni MA; Rosowsky A; Schornagel JH; Pinedo HM; Jansen G
    Biochem Pharmacol; 2002 Jan; 63(2):105-15. PubMed ID: 11841783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate transport in variant human CCRF-CEM leukemia cells with elevated levels of the reduced folate carrier. Selective effect on carrier-mediated transport of physiological concentrations of reduced folates.
    Jansen G; Westerhof GR; Jarmuszewski MJ; Kathmann I; Rijksen G; Schornagel JH
    J Biol Chem; 1990 Oct; 265(30):18272-7. PubMed ID: 2211701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A structurally altered human reduced folate carrier with increased folic acid transport mediates a novel mechanism of antifolate resistance.
    Jansen G; Mauritz R; Drori S; Sprecher H; Kathmann I; Bunni M; Priest DG; Noordhuis P; Schornagel JH; Pinedo HM; Peters GJ; Assaraf YG
    J Biol Chem; 1998 Nov; 273(46):30189-98. PubMed ID: 9804775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered transport of folic acid and antifolates through the carrier mediated reduced folate transport system in a human leukemia cell line resistant to (6R) 5,10-dideazatetrahydrofolic acid (DDATHF).
    Pavlovic M; Leffert JJ; Russello O; Bunni MA; Beardsley GP; Priest DG; Pizzorno G
    Adv Exp Med Biol; 1993; 338():775-8. PubMed ID: 8304227
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification of a membrane-associated folate-binding protein in human leukemic CCRF-CEM cells with transport-related methotrexate resistance.
    Jansen G; Westerhof GR; Kathmann I; Rademaker BC; Rijksen G; Schornagel JH
    Cancer Res; 1989 May; 49(9):2455-9. PubMed ID: 2706633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular metabolism of 5,10-dideazatetrahydrofolic acid in human leukemia cell lines.
    Pizzorno G; Sokoloski JA; Cashmore AR; Moroson BA; Cross AD; Beardsley GP
    Mol Pharmacol; 1991 Jan; 39(1):85-9. PubMed ID: 1702876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional aspects of membrane folate receptors in human breast cancer cells with transport-related resistance to methotrexate.
    Pinard MF; Jolivet J; Ratnam M; Kathmann I; Molthoff C; Westerhof R; Schornagel JH; Jansen G
    Cancer Chemother Pharmacol; 1996; 38(3):281-8. PubMed ID: 8646804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional activity of the reduced folate carrier in KB, MA104, and IGROV-I cells expressing folate-binding protein.
    Westerhof GR; Rijnboutt S; Schornagel JH; Pinedo HM; Peters GJ; Jansen G
    Cancer Res; 1995 Sep; 55(17):3795-802. PubMed ID: 7641196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular events in the membrane transport of methotrexate in human CCRF-CEM leukemia cell lines.
    Freisheim JH; Ratnam M; McAlinden TP; Prasad KM; Williams FE; Westerhof GR; Schornagel JH; Jansen G
    Adv Enzyme Regul; 1992; 32():17-31. PubMed ID: 1323203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifactorial resistance to 5,10-dideazatetrahydrofolic acid in cell lines derived from human lymphoblastic leukemia CCRF-CEM.
    Pizzorno G; Moroson BA; Cashmore AR; Russello O; Mayer JR; Galivan J; Bunni MA; Priest DG; Beardsley GP
    Cancer Res; 1995 Feb; 55(3):566-73. PubMed ID: 7834626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transport of folate compounds by leukemic cells. Evidence for a single influx carrier for methotrexate, 5-methyltetrahydrofolate, and folate in CCRF-CEM human lymphoblasts.
    Henderson GB; Tsuji JM; Kumar HP
    Biochem Pharmacol; 1987 Sep; 36(18):3007-14. PubMed ID: 3477231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of the disparate antitumor effects of (6R)5,10-dideaza-5,6,7,8- tetrahydrofolate and methotrexate toward methotrexate resistant CCRF-CEM cells, characterized by severely impaired antifolate membrane transport.
    Matherly LH; Angeles SM
    Adv Exp Med Biol; 1993; 338():783-6. PubMed ID: 8304229
    [No Abstract]   [Full Text] [Related]  

  • 16. Sensitivity to 5,10-dideazatetrahydrofolate is fully conserved in a murine leukemia cell line highly resistant to methotrexate due to impaired transport mediated by the reduced folate carrier.
    Zhao R; Gao F; Babani S; Goldman ID
    Clin Cancer Res; 2000 Aug; 6(8):3304-11. PubMed ID: 10955817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of folate transport mediated by a low pH route in mouse L1210 leukemia cells with defective reduced folate carrier function.
    Sierra EE; Goldman ID
    Biochem Pharmacol; 1998 May; 55(9):1505-12. PubMed ID: 10076544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the individual transport routes that mediate the influx and efflux of methotrexate in CCRF-CEM human lymphoblastic cells.
    Henderson GB; Tsuji JM; Kumar HP
    Cancer Res; 1986 Apr; 46(4 Pt 1):1633-8. PubMed ID: 3948152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pH dependence of methotrexate transport by the reduced folate carrier and the folate receptor in L1210 leukemia cells. Further evidence for a third route mediated at low pH.
    Sierra EE; Brigle KE; Spinella MJ; Goldman ID
    Biochem Pharmacol; 1997 Jan; 53(2):223-31. PubMed ID: 9037255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased expression of the human folate receptor mediates transport-defective methotrexate resistance in KB cells.
    Saikawa Y; Knight CB; Saikawa T; Page ST; Chabner BA; Elwood PC
    J Biol Chem; 1993 Mar; 268(7):5293-301. PubMed ID: 7680349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.